mycophenolate mofetil

mycophenolate mofetil (CELLCEPT) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.

CELLCEPT is a marketed brand name for mycophenolate mofetil. Check FDA Drugs@FDA for the current US label holder and prescribing information.

mycophenolate mofetil has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.